09. - 10.11.2017

Bonn: Projektmanagement in Regulatory Affairs

During this two days seminar, the attendees will learn important aspects of drug registration and project management. Dr. Hiltrud Horn will be one of the main speakers. Her talks will focus on project planning, regulatory strategies for EU and US as well as preparation of global dossiers (CTD). In a case study you will learn what needs to be considered for successful planning of a submission (MAA/NDA). Benefit from the case studies and avoid pitfalls. In this training course you will understand the typical challenges that a project manager in regulatory affairs has to face. You will understand how to select the right strategies in order to be successful and efficient for your projects. Take the chance and benefit from the long-term experience of the speakers.

For more information please visit the following website:

http://www.forum-institut.de/seminar/1711230-projektmanagement-in-regulatory-affairs

(Conference organized by FORUM Institut)

Back

HOTLINE

Phone +49 (0) 7251/305 529
Fax +49 (0) 7251/305 528
Mail

Events

  • 27.09.2019
    Frankfurt: Regulatorische Anforderungen an Primärpackmittel
    More
  • 08.-09.10.2019
    Heidelberg: Change Control – New Aspects and Best Practices
    More
  • 15.-17.10.2019
    Mannheim: Regulatory Compliance Expert - Arzneimittelzulassung für Mitarbeiter aus dem GMP-Umfeld
    More
Get all events



News

  • 10.03.2017
    News for the Industry
    More
  • 26.07.2013
    News on Change Control/Variations:
    More
  • 31.01.2013
    EU: Revised GMP-Annex 2 published - Details defined for biological products including ATMPs
    More
Get all news
EU: New Variation System in force as of Jan 1, 2010. Filing of variations will be faster, easier, and more flexible. Have you considered that your Change Control System needs to be updated accordingly?
EU: Centralised Marketing Authorisation Procedure for ATMPs needed Have you already filed your application? The time clock is ticking. Transitional periods will be over soon.
This website uses cookies. By using the website you agree to the use of cookies. Privacy Policy X